Advancing drug development through simulation
Simulations Plus (simulationsplus.com) earns a Brand Analyzer score of 68 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands, SaaS brands. Among 2305 Healthcare brands analyzed, Simulations Plus ranks in the 49th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 75/100, Digital Presence 100/100, Visual Identity 45/100, Messaging Clarity 95/100, Trust Foundation 90/100, AI Discoverability 35/100, Brand Authority 26/100.
Simulations Plus, founded in 1996 and headquartered in Lancaster, is a biosimulation software and consulting company serving the biopharmaceutical industry. It develops model-informed drug development tools that help predict drug behavior, aiming to improve the safety and efficacy of new therapies. Its offerings combine software with scientific consulting services used by pharmaceutical and biotechnology companies, research scientists, and regulatory agencies throughout drug discovery, development, and regulatory submission processes.
| Brand Name | Simulations Plus |
|---|---|
| Domain | simulationsplus.com |
| Industry | Healthcare, Technology |
| Founded | 1996 |
| Headquarters | Lancaster |
| Main Competitors | Certara (87/100), Schrödinger (87/100), Rosa & Co., Genedata, Nuventra (81/100) |
Moz Domain Authority 10/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Simulations Plus has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "To empower biopharmaceutical researchers with model-informed drug development software and services that improve the safety and efficacy of new therapies." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), Instagram, YouTube, GitHub; no detected presence on LinkedIn, Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Simulations Plus scores 46/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Simulations Plus has a limited AI-visibility profile at 46/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (63/100) and its weakest is trust (17/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 10/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Simulations Plus's main competitors include Certara, Schrödinger, Rosa & Co., Genedata, Nuventra. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Simulations Plus official site
Popular alternatives to Simulations Plus include Certara, Schrödinger, Rosa & Co., Genedata, Nuventra. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Simulations Plus official site
Simulations Plus offers an integrated suite of biosimulation software along with expert scientific consulting services. These tools and services support pharmaceutical and biotechnology companies in drug discovery, development, and regulatory submission by enabling prediction of drug behavior and supporting model-informed drug development processes.
Sources: Simulations Plus official site
Simulations Plus is a biopharmaceutical software and consulting company founded in 1996 and headquartered in Lancaster. It specializes in model-informed drug development (MIDD), providing biosimulation software and scientific services to the pharmaceutical and biotechnology industries.
Sources: Simulations Plus official site
Simulations Plus has limited AI-search visibility, scoring 46/100 on Brand Analyzer's AI visibility composite (visibility 63, trust 17, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Simulations Plus official site
Simulations Plus was founded in 1996. Simulations Plus operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Simulations Plus is headquartered in Lancaster. Simulations Plus operates in the Healthcare category.
Sources: Wikidata
Simulations Plus develops biosimulation software and offers expert scientific consulting to help biopharmaceutical companies predict drug behavior, streamline drug discovery and development, and support regulatory submissions. Its tools are designed to improve the safety and efficacy of new therapies while reducing development costs and risks.
Sources: Simulations Plus official site
Simulations Plus and Certara are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Simulations Plus official site
Simulations Plus scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Simulations Plus official site
Simulations Plus is used by pharmaceutical and biotechnology companies, regulatory agencies, and research scientists involved in drug discovery, development, and regulatory submission processes.
Sources: Simulations Plus official site
Simulations Plus is known for its integrated suite of biosimulation software used in model-informed drug development, which is trusted by pharmaceutical companies, biotechnology firms, and regulatory agencies worldwide to predict drug behavior and support the drug development process.
Sources: Simulations Plus official site
Simulations Plus can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Simulations Plus official site
Simulations Plus is recognized in the biopharmaceutical industry for its integrated biosimulation software combined with scientific consulting, which helps companies predict drug behavior, accelerate development timelines, and reduce costs and risks. Its trusted use by regulatory agencies and top drug developers contributes to its standing in the model-informed drug development space.
Sources: Simulations Plus official site
Ranked closest to Simulations Plus: Shubham EPC Private Limited (68/100), Serbanon (68/100), Subtle Medical (68/100), TestChecks (68/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).